CLINICAL_TRIALS
trial_result
· 2020-11-06
Clinical Trial Update: Evaluate Severe Hepatic Impairment on Dacomitinib PK [Phase 1]
Summary
Phase 1 trial update evaluating the pharmacokinetics of dacomitinib in patients with severe hepatic impairment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Severe Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2020-11-06